Pharma VC Funds

Dreamit Ventures is a leading venture capital firm that focuses on early-stage investments in Healthtech and Securetech startups. Founded in 2008, Dreamit has invested in over 350 companies, helping them scale revenues and achieve significant growth. Notable investments include SeatGeek, Redox, Eko, and Trendkite. Dreamit typically invests in companies that already have revenue or pilots, focusing on those ready to scale rapidly. The firm provides substantial support through its Customer Sprints® and Investor Sprints®, connecting founders with potential customers and investors. This approach helps startups gain traction and secure additional funding. Dreamit’s portfolio companies benefit from deep vertical expertise in cybersecurity, healthcare, and digital health, among other sectors. The firm is headquartered in New York and has a strong presence in the venture capital ecosystem, with a wide network of partners and advisors. Dreamit's investments are characterized by a focus on transformative technology and innovative solutions that address critical needs in their respective industries. For startups looking to engage with Dreamit, it is essential to demonstrate a clear path to revenue growth and scalability. The firm values strong, actionable business plans and provides ongoing support to help companies navigate the challenges of early-stage growth.

Drive Capital is a prominent venture capital firm based in Columbus, Ohio, founded in 2013 by Mark Kvamme and Chris Olsen, both of whom previously worked at Sequoia Capital. The firm focuses on investing in technology startups outside of Silicon Valley, with a particular emphasis on the Midwest, aiming to prove that world-class technology companies can emerge from any region in the United States. Drive Capital has raised over $2 billion to invest in startups solving significant problems in large markets. They have backed more than 80 companies, including notable investments like Duolingo, Root Insurance, Olive, Greenlight, and ApplyBoard. The firm is stage-agnostic, investing in seed, early-stage, and later-stage companies across various sectors such as healthcare, consumer services, information technology, and life sciences. The firm operates with a strong conviction in the potential of entrepreneurs from non-traditional tech hubs and emphasizes long-term partnerships. They seek out market-defining companies and prefer to journey with their portfolio companies from inception to IPO. Drive Capital's strategy is deeply rooted in leveraging local talent and resources, ensuring startups have the best advantages by building where they are strongest. Drive Capital's team includes a diverse group of investors committed to supporting founders with honesty and strategic guidance. They maintain a robust network and offer substantial resources to help startups navigate their growth trajectories. For entrepreneurs looking to engage with Drive Capital, the firm values bold, innovative ideas that address large market opportunities and demonstrate potential for significant impact​.

Droia Ventures is a Belgium-based venture capital firm that specializes in early-stage biotech investments, focusing exclusively on oncology and genetic diseases. With over €450 million under management, Droia supports young drug development companies that leverage cutting-edge science to bring breakthrough therapies to patients. Their portfolio includes companies such as Actio Biosciences and Vicinitas Therapeutics, which are focused on drug discovery in these high-impact areas. The firm’s investment strategy is highly targeted, aiming to fill the unmet medical needs in cancer treatment and genetic diseases like cystic fibrosis and hemophilia. Droia’s funds typically invest in newly founded or early-stage platform companies, often providing both financial backing and scientific expertise to help startups develop first-in-class drug candidates. Droia’s global reach is evident in its investments across the U.S. and Europe, with check sizes typically in the seed and early venture stages. Led by experienced partners like Janwillem Naesens and industry veteran George Golumbeski, Droia emphasizes long-term partnerships and active involvement in the scientific and business growth of its portfolio companies​.

DSM Venturing, the corporate venture arm of DSM, focuses on investing in innovative startups that align with its mission of improving health, nutrition, and bioscience. Since its inception in 2001, DSM Venturing has invested in over 100 startups across these sectors. Their portfolio includes companies such as NutriLeads, which develops food ingredients with health benefits, and Deep Branch Biotechnology, which converts carbon dioxide into sustainable animal nutrition products. Geographically, DSM Venturing is particularly active in North America and Europe. They typically invest between €1 million and €20 million over the lifetime of a venture, starting with initial investments ranging from €100k to €5 million. They take minority ownership stakes and often lead investment rounds while actively participating in the board activities of their portfolio companies​. DSM Venturing's investment strategy focuses on startups that offer transformative solutions in health, nutrition, and care, as well as animal nutrition and health, and food innovation. They aim to support these companies not only with funding but also with access to DSM's extensive scientific and commercial resources, fostering innovations that have the potential to make significant societal impacts​.

Dundee Venture Capital, founded in 2010 and based in Omaha, Nebraska, focuses on early-stage investments in high-growth technology companies. The firm is known for its hands-on approach and leadership in seed rounds, frequently leading 90% of their investments. Dundee VC invests predominantly in e-commerce, fintech, and SaaS, with notable portfolio companies including Summersalt, a direct-to-consumer lifestyle brand, and Omnia Fishing, an e-commerce platform for anglers. Their recent investments include Nyla, a no-code platform for e-commerce, and Pear Commerce, which aids grocery retailers with digital marketing. Dundee Venture Capital’s strategy emphasizes funding transformative startups located outside traditional coastal hubs. They seek companies with a strong vision, early traction, and a unique edge. With a commitment to seed-stage investing, Dundee is particularly interested in businesses that have potential for significant impact and rapid growth. The firm prefers to engage with founders who have a clear and compelling vision and are tackling urgent and valuable problems. The team, led by founder Mark Hasebroock, brings deep entrepreneurial experience and a track record of success, including the sale of Hayneedle to Walmart. Startups should approach Dundee with a robust business plan that demonstrates significant potential and a differentiated market approach.

Dutch Founders Fund (DFF) is an Amsterdam-based early-stage venture capital fund established by a group of successful Dutch entrepreneurs, including Laurens Groenendijk (Just Eat, Treatwell, Miinto), Patrick Kerssemakers (fonQ), Bas Beerens (WeTransfer), Hidde Hoogcarspel (Spacebuzz), and Remco van Zanten (ex-Booking.com, Zalando). The fund focuses on investing in marketplaces, network effects-driven propositions, and marketplace enablers across Europe. Notable investments by DFF include VonWood, which revolutionizes the wood industry with a transparent supply chain solution; Kennek, a SaaS-enabled marketplace for the alternative credit space; and Metycle, a global marketplace for scrap and recycled metal. Another significant investment is Mtor, an automotive parts marketplace in Egypt, addressing logistics and price transparency challenges. Additionally, HomeCooks, a foodtech platform in the UK, allows home chefs to sell their homemade dishes to a wider audience. DFF's investment strategy emphasizes providing intense mentoring from ideation to Series A, seeking companies that offer sustainable solutions and efficiency. They value founders who are ambitious, coachable, and ready to face challenges head-on. The fund is committed to simplicity, transparency, and equal distribution, ensuring every stakeholder gets a fair share of the value created. The team, with extensive experience and a strong track record in building successful companies, offers more than just capital. They dive deep into the operational aspects of their portfolio companies, providing hands-on support to help them grow and succeed.

Dynamk Capital is a New York-based venture capital firm that specializes in investing in early-stage companies within the life sciences sector, particularly focusing on life science industrials. Established in 2016, Dynamk Capital targets startups that develop critical tools, technologies, and services essential for the discovery, development, and manufacturing of life-saving therapies. The firm plays a pivotal role in advancing innovative solutions across the biopharma continuum, from drug discovery to development and production. Dynamk Capital's investment strategy is centered around providing both capital and strategic support to early-stage companies, helping them scale and succeed in a highly competitive and complex industry. The firm's portfolio includes a diverse range of companies, such as RoosterBio, which specializes in cell and exosome manufacturing, and Virica Biotech, which focuses on enhancing viral vector manufacturing for gene therapy. These investments reflect Dynamk's commitment to driving innovation in biomanufacturing and life sciences. The firm recently closed its inaugural life sciences fund at $65 million, marking a significant milestone in its mission to support groundbreaking life science ventures. Dynamk Capital continues to be an active player in the venture capital space, leveraging its industry expertise to identify and nurture companies that have the potential to make substantial contributions to healthcare and biopharmaceutical advancements.

Dynamo Ventures, established in 2016 and headquartered in Chattanooga, Tennessee, is a seed-stage venture capital firm that focuses on supply chain and mobility technology. The firm is known for investing in startups that address critical issues in the logistics, transportation, and supply chain sectors. Dynamo Ventures typically invests between $250,000 and $1.2 million per seed-stage company. Their notable portfolio includes Sennder, a German digital freight brokerage that recently achieved unicorn status with a valuation of $1.45 billion. Other significant investments are STORD, a digital warehouse and distribution network based in Atlanta, and Shipamax, a digital platform for bulk shipping. Additionally, they have backed companies like Skupos, a data analytics platform for convenience stores, and Celadyne Technologies, which focuses on advanced materials for batteries. Dynamo's investment strategy is centered around providing not only capital but also extensive industry expertise and network connections to help their portfolio companies succeed. The firm recently raised $43.21 million for their second fund, more than doubling the size of their first fund, which indicates strong investor confidence in their focused approach.

Eagle Venture Fund is a venture capital firm based in Fort Worth, Texas, with additional offices in Zurich and Singapore. Founded with a mission to drive both financial returns and significant social impact, Eagle Venture Fund focuses on early-stage investments in startups that tackle major societal challenges such as human trafficking, poverty, and healthcare for underserved populations. The firm operates several funds, including the Eagle Venture Fund IV, Eagle Freedom Fund, and Eagle City Fund. These funds support companies that are not only profitable but also dedicated to creating sustainable and exponential impacts. For example, the Eagle Freedom Fund specifically targets initiatives combating modern slavery and human trafficking. Eagle's investment approach is deeply integrated with their Venture Builder Engine, which provides startups with extensive support in areas such as strategic counsel and founder development. This hands-on approach helps portfolio companies scale effectively while staying true to their mission-driven goals. The leadership team at Eagle includes experienced professionals like Wes Lyons and Wade Myers, who bring a wealth of experience in both venture capital and impact investing. The firm has built a strong reputation for backing bold entrepreneurs who are passionate about creating change in areas where it’s most needed​.

Earlybird Venture Capital, founded in 1997, is a leading European venture capital firm with a strong focus on technology innovators. They manage around €2 billion in assets and have invested in over 220 companies across various sectors including digital technologies, healthcare, and deep tech. Earlybird operates four specialized funds: Digital West, Digital East, Health, and Earlybird-X, each targeting different geographies and technological areas. Notable investments include UiPath, a global leader in robotic process automation, and N26, a mobile banking platform. Earlybird has achieved significant exits through IPOs and trade sales, contributing to its reputation as one of Europe’s most experienced venture investors. Earlybird's strategy involves not only providing financial resources but also strategic support and access to an international network, aiding portfolio companies in scaling and succeeding in global markets. The firm is committed to sustainable practices and expects the same from its portfolio companies. For startups looking to engage with Earlybird, demonstrating innovative technology and scalability, particularly within Europe, can increase the likelihood of securing investment. The firm’s hands-on approach and extensive network provide substantial support to their portfolio companies, fostering growth and market success.

East Ventures is one of Southeast Asia's most active venture capital firms, known for backing some of the region's most successful startups. With investments in Tokopedia, Traveloka, Xendit, and Carro, it has a strong track record of nurturing unicorns. The firm primarily focuses on sectors like fintech, healthcare, SaaS, and logistics, with an emphasis on Indonesia, where it helps drive digital and economic growth. Recent investments include AWST (Web3), McEasy (telematics), and Rekosistem (waste management), reflecting its broad sectoral interest. East Ventures typically invests at the seed stage but also participates in growth rounds through its EV Growth Fund. It operates across multiple locations, including Jakarta, Singapore, and Japan, and is deeply committed to sustainability, with goals like achieving net-zero emissions by 2050. The firm supports ESG initiatives across its portfolio and actively engages in environmental projects such as mangrove reforestation. Co-founded by Willson Cuaca, Roderick Purwana, and Melisa Irene, East Ventures is recognized globally, having been ranked among the most active VCs by Pitchbook and CB Insights. The firm maintains a founder-centric philosophy, investing in people and markets over products, which has been key to its long-term success.

Eastlink Capital, founded in 2014 and headquartered in Menlo Park, California, is a venture capital firm focused on early and growth-stage investments in enterprise software, cloud infrastructure, AI, and data-driven technologies. Led by Steven Xi, the firm specializes in identifying high-potential startups that leverage unique technologies to solve critical problems in large markets. Their approach is deeply technical, often helping portfolio companies refine their product strategies and expand into new markets. Eastlink’s investment strategy is centered on mission-driven founders and innovative technologies, particularly in the AI, cloud-native, and data infrastructure sectors. Some of their prominent investments include StreamNative, TigerGraph, and MotherDuck, showcasing their commitment to supporting companies that build foundational enterprise technologies. What sets Eastlink apart is their cross-border expertise and a strong network, which they use to help their portfolio companies scale globally. Beyond providing capital, the team is known for being hands-on, offering strategic advice and connecting startups with key industry executives and partners. Eastlink has a track record of successful exits, including companies like Evernote and Sensely. The firm’s leadership team includes experienced investors like Eric Ye, who brings a wealth of knowledge in cloud-native infrastructure, and other seasoned advisors who provide deep technical insights and guidance to the companies they back. Eastlink Capital is well-positioned to support startups aiming to disrupt enterprise markets with groundbreaking technologies.

Eastward Capital Partners is a venture debt and equity financing firm specializing in technology-enabled businesses. With a portfolio of over 160 companies across sectors like SaaS, health technology, and B2B services, they offer non-dilutive capital that helps startups extend their cash runway without sacrificing equity. Notable investments include companies such as GoSecure, Lightmatter, and Survios. Eastward typically partners with leading venture capital firms, favoring innovative firms in high-growth sectors like cybersecurity, enterprise software, and e-commerce solutions. Geographically, they focus on U.S.-based companies, with a preference for those in the Northeastern region. Their strategy emphasizes flexible financing structures that avoid restrictive covenants, making them an attractive choice for scaling startups. They also tend to co-invest alongside established VCs, complementing equity funding rounds with venture debt to optimize the company's capital structure. Led by Dennis Cameron, with nearly four decades of experience in structured finance and venture debt, Eastward Capital brings deep expertise to its partnerships. Startups seeking funding can benefit from their extensive industry knowledge and active involvement in structuring deals that align with business goals.

Eclipse Ventures, founded in 2015 and headquartered in Palo Alto, California, is a venture capital firm that focuses on transforming essential industries through innovative technology. The firm has over $2 billion in assets under management and invests in sectors such as manufacturing, logistics, supply chain, energy, healthcare, and transportation. Notable investments in their portfolio include VulcanForms, which develops advanced digital manufacturing infrastructure; Augury, providing machine health insights; Enovix, designing advanced lithium-ion batteries; and Cellares, which offers scalable cell therapy manufacturing solutions. Eclipse Ventures has made over 108 investments and has seen 11 successful exits, including companies like Light and Veev. The firm typically invests across various stages, from pre-seed to Series D, and aims to modernize physical industries that are critical to the economy. Their team is composed of experienced operators and investors who provide strategic support and resources to help portfolio companies grow and succeed.

Educapital is a leading European venture capital firm founded in 2017, dedicated to investing in the Edtech and Future of Work sectors. Based in Paris, France, Educapital focuses on supporting innovative companies that aim to transform education and the workplace through technology. The firm was co-founded by Marie-Christine Levet and Litzie Maarek, marking it as the first independent VC firm in Europe founded by women. With $200 million in assets under management, Educapital is the largest European fund in its niche, investing in startups from late seed to Series B stages with check sizes ranging from €3 million to €10 million. Their portfolio includes over 30 companies that are making significant impacts in education and the future of work, such as an online school for entrepreneurship, a collaborative learning management system, and platforms for immersive science learning and career guidance. Educapital’s investment thesis revolves around backing mission-driven entrepreneurs with strong leadership, focusing on companies that have the potential to become global leaders and contribute to building a sustainable society. The firm’s impact-driven approach ensures that their investments not only generate financial returns but also drive significant positive changes in the educational landscape.

eHealth Ventures, founded in 2014, is a digital health-focused venture capital firm based in Israel. It primarily invests in early-stage startups, focusing on innovative technologies that drive the transition from hospital care to home care and predictive healthcare solutions. With over $70 million in assets under management, the firm operates a unique investment structure, providing both capital and extensive support to its portfolio companies. Their investments target pre-seed to early-stage rounds, often leveraging non-dilutive funding from the Israeli Innovation Authority. eHealth Ventures boasts a diverse portfolio of over 30 startups, including companies like AccuLine, which is developing a non-invasive heart attack detection test, and GaitBetter, an AI-driven platform for fall prevention and rehabilitation. The firm’s strategic partnerships with healthcare heavyweights such as Maccabi Healthcare Services, Amgen Ventures, and the Mayo Clinic allow its portfolio companies access to vast medical networks and commercial opportunities across the globe. Led by CEO Talor Sax, eHealth Ventures plays a pivotal role in nurturing digital health startups, providing hands-on guidance from the early stages through to commercialization. The firm’s mission is to address pressing healthcare challenges by investing in solutions that improve accessibility, reduce costs, and enhance patient care. Its approach is deeply rooted in collaboration, bringing together industry leaders, healthcare providers, and technologists to shape the future of digital health.

Eight Roads Ventures, founded in 1969, is a global venture capital firm and the corporate investment arm of Fidelity International. The firm manages over $11 billion in assets and has a significant presence in major markets including the UK, China, India, Japan, and the US. Eight Roads focuses on investing in technology and healthcare sectors, backing companies from early to growth stages. Eight Roads has built an impressive portfolio with over 300 active companies and 19 unicorns, including notable names like AppsFlyer, Icertis, and Akulaku. The firm is also known for its strong support network, providing not just capital but also strategic guidance and resources to help its portfolio companies scale globally. The firm recently launched a $375 million fund focused on Europe and Israel, targeting sectors such as enterprise technology, consumer, fintech, and healthcare IT. This fund aims to make 15 to 20 investments of $10 million to $30 million each​. Eight Roads' team includes seasoned professionals like Daniel Auerbach, Senior Managing Partner & Head of Global Ventures, and Jarlon Tsang, Managing Partner & Head of China, who bring extensive experience and expertise to the firm's operations.

Eka Ventures is a London-based venture capital firm founded in 2018 by Camilla Dolan, Jon Coker, and Andrew Richardson. The firm is dedicated to investing in early-stage startups that aim to create a positive system change, focusing on companies that promote sustainability, health, and inclusivity. Eka Ventures primarily invests in the seed and Series A stages, with typical check sizes ranging from £0.5 million to £3 million. The firm’s portfolio includes a diverse range of companies, such as Byway, a sustainable travel platform, and Hived, a green logistics startup. Eka Ventures is particularly interested in technology-driven businesses that leverage data and science to build solutions that can scale and make a significant impact on the economy and environment. Eka’s strategy revolves around partnering with mission-driven founders who are building category-defining technology companies. The firm is known for its hands-on approach, working closely with founders to support their growth and scale their businesses. With all of its team members based in London, the firm emphasizes a collaborative and supportive environment, providing not only capital but also strategic guidance and operational support. For startups seeking investment, Eka Ventures values a clear mission-driven approach that aligns with their focus on sustainability and positive impact. The firm’s founders have a strong background in consumer technology and a deep commitment to backing companies that aim to solve critical global challenges.

Elaia Partners is a leading European venture capital firm focused on investing in digital and deep tech startups from early-stage to growth development. Founded in 2002 and headquartered in Paris, Elaia manages over €700 million in assets. The firm has built a strong reputation for backing ambitious tech entrepreneurs, with notable investments in companies like Mirakl, Shift Technology, Ornikar, and iBanFirst. Elaia's investment strategy emphasizes supporting disruptive technologies and innovative business models across various sectors, including SaaS, AI, fintech, and health tech. They typically invest in early-stage companies with high growth potential, providing both capital and strategic guidance to help these startups scale globally. Their portfolio includes over 100 investments and 80 successful exits, showcasing their ability to identify and nurture high-potential startups. The firm is known for its close relationships with deep tech academia and its commitment to ESG principles. Elaia's team consists of experienced investors and entrepreneurs who work closely with portfolio companies to drive growth and achieve long-term success. The firm's recent launch of the Elaia Delta Fund, which secured €115 million in its initial closing, underscores their ongoing commitment to supporting tech disruptors.

Elementum Ventures, founded in 2014 and based in Menlo Park, California, is a venture capital firm that focuses on investing in seed-stage deep technology companies. The firm targets large markets with intellectual property as their primary differentiation and defensibility, emphasizing emerging technologies that are on the cusp of commercialization. They provide not only capital but also strategic support through their network of strategic partners, advisors, and potential customers. Elementum Ventures has a notable portfolio that includes companies like Anduril, a defense technology company, and Fathom Radiant, which works on advanced AI hardware. They also invest in diverse sectors such as consumer products, virtual reality, augmented reality, artificial intelligence, and machine learning. The firm's team includes General Partners Ben Chelf, Ben Patterson, and Kurt Keilhacker. Ben Chelf co-founded Coverity, which was later acquired by Synopsys. Ben Patterson has a background in music and IT infrastructure, while Kurt Keilhacker has co-founded and invested in over 50 companies across the US and Europe. For startups looking to engage with Elementum Ventures, demonstrating strong intellectual property and the potential for significant market impact can be advantageous. The firm's deep involvement and extensive network support can provide significant value to early-stage ventures​.

Elevat3 Capital is the venture capital arm of Christian Angermayer's Apeiron Investment Group, a global investment firm with over $2.5 billion in assets under management. Elevat3 focuses on investing in high-growth technology companies across Europe, often leading or co-leading rounds with ticket sizes ranging from $5 million to $20 million. The firm targets industries undergoing significant change, particularly in sectors like life sciences, fintech, and future technologies. The team at Elevat3 is known for its hands-on approach, providing strategic support beyond just capital to help portfolio companies scale effectively. With a presence in key locations like Berlin, London, and New York, Elevat3 leverages a robust network and deep industry expertise to drive value creation in its investments. Some of the notable investments include Gropyus, a company focused on sustainable building technologies, and Formo, which is pioneering the production of cultured dairy products. The firm’s investment strategy emphasizes finding and activating key "triggers" that can significantly elevate a company’s valuation and market position.

Elevate Capital is a pioneering venture capital fund with a mission to support underserved entrepreneurs, including women, minorities, veterans, and those with limited regional access to capital. Since its launch in 2016, Elevate has made significant investments in diverse founders across various industries such as healthcare, fintech, cybersecurity, and SaaS. Notable investments include startups like Troy Medicare and Blendoor. Focusing on pre-seed to Series A stages, Elevate typically invests between $25k to $2 million. Their strategic emphasis is on scalable startups founded by underrepresented groups, aiming to foster generational wealth and economic impact. They primarily target companies in Oregon through the Innovation Gap Fund, but their Capital Fund II extends investments nationally. The fund's approach is deeply rooted in active mentorship and hands-on support, leveraging the extensive experience of its team members. Key figures include Managing Partner Nitin Rai, who is instrumental in guiding the fund's inclusive investment strategy. Other notable team members are Lateef Jackson, focusing on healthcare technology, and Giovanni, who brings expertise in global strategy and market development. Elevate Capital's proactive outreach and strategic networking are key elements in building their investment funnel. Entrepreneurs are encouraged to approach them via warm introductions or direct contact through their website. By prioritizing diversity and inclusion, Elevate Capital stands out in the venture capital landscape, driving meaningful change and supporting the next generation of visionary founders.

Elizabeth Street Ventures is an early-stage venture capital firm based in New York, specializing in the digital consumer space. Founded in 2018, the firm focuses on businesses that are transforming how people shop, interact, and live by funding category-defining products and services. Their investments target sectors like digital commerce, consumer fintech, and health and wellness, with a strong emphasis on enhancing the customer experience. The firm typically participates in seed and pre-seed rounds, with average check sizes ranging between $500K and $750K. Notable portfolio companies include Rise Brewing Co., Oros, and SimpliFed, showcasing their interest in innovative consumer brands that push boundaries in sustainability, wellness, and technology. Elizabeth Street Ventures often co-invests with other top-tier investors, leveraging their vast network to help portfolio companies scale effectively. Led by co-founders Will McClelland and Ben Sontheimer, the firm prides itself on being highly selective, focusing on building long-term relationships with founders who are passionate about reimagining consumer experiences. They follow a hands-on approach, providing strategic guidance, operational support, and key industry connections to help companies grow. The team’s diverse expertise, ranging from consumer retail to financial technology, positions Elizabeth Street Ventures as a trusted partner for early-stage entrepreneurs aiming to disrupt traditional industries and create market-leading brands.

Embark Ventures, based in Santa Monica, California, is a venture capital firm specializing in pre-seed and seed-stage investments. Founded in 2017 by Peter Lee and Yipeng Zhao, the firm focuses on "deep tech" companies that possess proprietary technology offering a significant competitive advantage in transforming multi-billion dollar industries. The sectors they target include bio-healthcare, software and computing, manufacturing and industrial, material science, robotics and automation, and sensors and semiconductors​. Embark Ventures has made numerous notable investments, including companies like Truvian Sciences, Parallel Systems, Kula Bio, and Machina Labs. Their strategy involves backing ambitious teams with breakthrough technologies that can disrupt large markets. The firm typically invests between $100,000 and $2 million in their portfolio companies​.

Emerald Technology Ventures, founded in 2000, is a prominent venture capital firm based in Zurich, Switzerland, with offices in Toronto and Singapore. The firm specializes in investments in clean technology, targeting sectors such as energy, water, wastewater, materials, packaging, mobility, urbanization, food, and agriculture. With assets under management exceeding €1 billion, Emerald has made significant contributions to the advancement of sustainable technologies. Emerald's portfolio includes a variety of innovative companies. Notable investments include SewerAI, a leader in AI and cloud-driven sewer condition assessment, and SpotLight, which develops non-invasive subsurface surveillance solutions for carbon dioxide geological storage. Other significant investments are in companies like Kalpana Systems and VYTAL, which focus on semiconductor technology and reusable packaging solutions, respectively. The firm has also achieved successful exits with companies such as Rhombus Energy Solutions, DeepSea Technologies, and Spear Power Systems, showcasing its ability to nurture and scale startups towards successful outcomes. Emerald's investment strategy is driven by a commitment to tackling major challenges in climate change and sustainability, leveraging their expertise and extensive network to support groundbreaking innovations in these fields. Emerald's team comprises experienced professionals, including Hans Dellenbach, Markus Moor, and Christoph Frei, who bring a wealth of knowledge and strategic insight to their portfolio companies. Their approach combines financial investment with strategic support, ensuring that their portfolio companies can thrive and make a substantial impact on their respective industries.

Emerge Education, founded in 2013 by Jan Lynn-Matern, is a London-based venture capital firm that specializes in early-stage investments in educational technology companies. The firm’s mission is to democratize access to opportunity by being a catalytic partner for early-stage edtech founders. Emerge Education focuses on sectors such as higher education, lifelong learning, and the future of work, investing primarily in pre-seed and seed stages across Europe and North America. Emerge Education is distinguished by its backing from over 100 of the world's leading edtech operators, offering founders unparalleled insights and support from industry experts. Their typical investment ranges from £250,000 to £1.5 million, and they provide hands-on support to help startups scale and succeed. Notable investments in their portfolio include companies like Tomorrow University of Applied Sciences, Causaly, Unibuddy, and Mentor Collective, which are driving innovation in various aspects of education and workforce development​ (Emerge Education)​​ (PitchBook)​. Emerge Education has also seen successful exits, such as Zavvy and Kide Science, showcasing their effective investment strategy and support mechanisms. For startups looking to partner with Emerge Education, demonstrating strong alignment with their focus on transformative education technologies and a clear ambition to become global category leaders is key.

Emergence Capital Partners Limited is a full-fledged financial services company specializing in fixed income brokerage and business and financial advisory services. Based in Africa, the firm engages in trading treasury bills, corporate bonds, and government bonds, offering clients opportunities for stable, fixed returns on mid to long-term investments. The firm also provides bespoke, one-on-one financial advisory services, tailored to meet the unique needs of its clients, from retail investors to high-net-worth individuals and institutions. Founded with the mission to drive high-growth potential and sustainable businesses, Emergence Capital partners with early-stage companies and founding teams across Africa. The firm is often among the first to invest, using a variety of strategies and instruments that are best suited to the markets in which they operate. Their advisory services are comprehensive, helping companies navigate financial challenges and achieve their business objectives. The team at Emergence Capital is comprised of experienced professionals with extensive backgrounds across various sectors, leveraging their expertise to deliver superior value and outcomes for their clients.

Emerson Collective, founded by Laurene Powell Jobs, is a unique blend of philanthropy and impact investing focused on education, immigration, the environment, media, and health. Notable investments include AltSchool, College Track, and XQ Institute, emphasizing their commitment to transforming education and creating social impact. They invest globally but have a strong presence in the US. Their strategy involves partnering with innovative entrepreneurs and providing not just capital but also strategic support to scale impactful solutions. The team is composed of experts from various fields, ensuring a comprehensive approach to addressing complex social issues.

Emles Venture Partners, founded by seasoned entrepreneurs with successful exits, offers a dynamic approach to venture capital investment. Known for their swift decision-making, Emles provides investment verdicts within 72 hours, ensuring startups can maintain momentum. The firm is distinguished by its diverse portfolio, with 45% of founders being female or from diverse backgrounds, and 55% being international. Emles invests across various industries without sector or geographic constraints, focusing on seed-stage companies and supporting them through their growth stages with follow-on investments in 75% of cases. Notable investments include 1910 Genetics, Shiru, Zeta Surgical, and Arist, each recognized for innovative contributions in their respective fields. Key team members include Gabriel Hammond, a partner with significant experience and two company exits, Emanuel Zareh, and Rachel Deinhart, specializing in venture debt. Emles emphasizes personal capital investment, having committed $25 million to empower founders. Their strategic approach involves offering bridge capital and unique debt offerings to optimize the cost of capital, maximizing founders' equity. Emles is celebrated for its lack of bureaucratic constraints, focusing solely on the best ideas, and supporting founders with operational guidance and strategic insight. Founders praise the firm for its unwavering support and commitment through multiple funding rounds, making Emles a preferred partner for ambitious startups.

Empede Capital is a venture capital firm established in 2021, with a focus on disruptive technologies across various sectors. Headquartered in Tortola, British Virgin Islands, with additional offices in the UAE and the UK, Empede Capital primarily invests in Seed to Series B startups. The firm’s expertise spans industries like cyber technology, construction technology, healthcare, agriculture, fintech, cloud, virtual reality, drone technology, and more. Empede Capital emphasizes innovation and scalability, investing in companies that leverage emerging technologies to disrupt traditional industries. Some of its notable portfolio investments include Instacart, Better.com, Digital Ocean, and Axiom Space. The firm's founding partners, including Mukund Hirani, Prakash Senghani, Raj Varsani, and Dinesh Dabasia, bring extensive experience from sectors like cyber, real estate, and construction, which they use to provide both financial support and strategic guidance to the startups they back. Empede Capital's approach focuses on providing "smart capital," leveraging its domain expertise to help companies scale and achieve industry disruption.

Endeit Capital is a venture capital firm based in Amsterdam, with additional offices in Hamburg and Stockholm. Since its inception in 2006, Endeit Capital has been a driving force in scaling European tech companies, focusing on digital media, SaaS, and e-commerce. Their notable portfolio includes investments in Lepaya, a B2B training platform, and successful exits like 3D Hubs, acquired by Protolabs for $330 million, and neo-broker BUX. Endeit primarily invests in later-stage startups, providing growth capital typically between €7 million and €15 million. Their strategy emphasizes fueling internationalization and innovation, preferring companies with strong market potential and scalable business models. They usually lead funding rounds, demonstrating a hands-on approach in their partnerships. Endeit Capital's investment activities are geographically centered in Europe, with a significant focus on the Benelux region and Germany. They have a robust network, collaborating with 72 entrepreneurs and several co-investors. The team at Endeit Capital is composed of seasoned professionals like co-founders Hubert Deitmers and Joop van den Ende, both based in Amsterdam. Key partners include Martijn Hamann and Ilan Goudsmit, who bring extensive experience in software, marketplaces, and mobile industries. For startups seeking investment, Endeit Capital values a clear demonstration of cultural fit and mission-driven goals. They build their funnel through proactive deal flow generation and maintaining strong industry connections, making them a preferred partner for ambitious tech scale-ups looking to expand their footprint in Europe.

Endiya Partners, founded in 2015 and based in Hyderabad, India, is an early-stage venture capital firm focusing on deep tech, healthcare, and enterprise technology. The firm is known for its significant contributions to the startup ecosystem, particularly in supporting innovative and scalable businesses. Endiya's portfolio includes a variety of notable investments. For instance, Darwinbox, a comprehensive HR management platform; Kissht, a consumer credit platform; and Cult.fit, a health and wellness company. Additionally, their investments in the healthcare sector include SigTuple, which utilizes AI for medical diagnostics, and EKincare, a health benefits platform offering preventive and personalized healthcare services. The firm has seen successful exits such as ShieldSquare, acquired by Radware, and Steradian Semiconductors, acquired by Renesas. Endiya Partners has been actively deploying its second fund, which closed at $75 million in 2021, to continue supporting promising startups. Key team members include co-founders Sateesh Andra, Ramesh Byrapaneni, and Abhishek Srivastava, who bring extensive industry experience and a strong network to help their portfolio companies grow and succeed.

Endure Capital, founded in 2015 by Tarek Fahim, is an early-stage investment fund based in Cairo, Egypt. The firm focuses on investing in startups across various sectors, including technology, healthcare, fintech, and foodtech. With an asset under management (AUM) of $85 million, Endure Capital has invested in 52 companies and has had significant exits, including Careem, which was acquired by Uber for $3.1 billion. The firm's notable investments include regional leaders like MaxAB, a B2B e-commerce platform, and Breadfast, a pioneering grocery delivery startup. Internationally, their portfolio features companies like Boom Supersonic and Aspect Biosystems. Endure Capital typically invests in pre-seed, seed, Series A, and Series B rounds, with ticket sizes ranging from $1 million to $5 million. Endure Capital recently closed the first round of its $50 million fund, Endure 21, aimed at impact-driven early-stage startups in Africa and selectively investing in growth-stage startups globally. The firm is expanding its reach into North America and Saudi Arabia, launching the Arak Fund in partnership with Awaed Capital, which focuses on various advanced sectors including space technology and AI infrastructure. Endure Capital also emphasizes long-term support and mentorship for its portfolio companies through initiatives like “Endure... Pay it Forward,” reflecting its commitment to nurturing a vibrant startup ecosystem.

Eniac Ventures is a premier seed-stage venture capital firm with a notable portfolio including Hinge, Headspace, and Tapad. Focused on AI, SaaS, healthcare, and deep tech, Eniac invests primarily in U.S.-based companies. The firm typically leads seed rounds with average check sizes ranging from $500K to $1M, and is renowned for its hands-on approach and strategic support. Co-founders Hadley Harris and Nihal Mehta leverage their extensive entrepreneurial backgrounds to guide startups towards success. Eniac prefers pitches that demonstrate strong technical foundations and significant market potential. They have been especially active recently, seeking bold, transformative startups that can redefine their industries. For founders, a warm introduction and a well-prepared, concise pitch are key to gaining their attention. Eniac’s team is dedicated to fostering innovation and driving growth, positioning themselves as valuable partners in the startup ecosystem.

Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.

Entrée Capital, a global venture capital firm founded in 2010, provides multi-stage funding for innovative startups from pre-seed to growth stages. They manage over $1.25 billion across nine funds, focusing heavily on fintech, deep tech, SaaS, AI, blockchain, and e-commerce sectors. Their notable investments include Monday.com, Coupang, Stripe, and Cazoo. Based in Tel Aviv, Israel, with additional offices in London and New York, Entrée Capital primarily targets investments in Israel, the U.S., and Europe. The firm’s strategy involves supporting startups from the idea stage through to scaling, providing both capital and strategic guidance. They actively lead funding rounds and offer extensive mentorship and market insights to help portfolio companies navigate growth challenges. Key team members include Aviad Eyal, co-founder and managing partner, and Eran Bielski, general partner. Both bring extensive experience in venture capital and entrepreneurship, contributing to the firm's strong track record of successful investments and exits. Entrée Capital has backed over 180 startups, achieving more than 27 exits and IPOs, and supporting over 17 unicorns. The firm’s approach emphasizes building strong, long-term relationships with founders and aligning closely with their visions. They are particularly accessible through direct contact on their website and prefer pitches that demonstrate clear, innovative business models and strong market potential.

Entrepreneur First (EF) is a global talent investor founded in 2011 by Alice Bentinck and Matt Clifford. EF's unique approach focuses on helping individuals build technology companies from scratch, often before they have a team or specific idea. This model emphasizes selecting ambitious individuals based on their potential and providing them with the resources to find co-founders and develop their startups. Operating in major cities such as London, Singapore, Berlin, Paris, Bangalore, and Toronto, EF has successfully created over 500 companies with a combined valuation exceeding $10 billion. Some of their most notable investments include Tractable, a computer vision company valued at $1 billion; Magic Pony Technology, which was acquired by Twitter for $150 million; and Omnipresent, a remote HR platform. EF typically invests around £80,000 in each startup in Europe, C$100,000 in Canada, and SG$75,000 in Asia, in exchange for a 10% equity share. Their portfolio boasts significant exits like Deliveroo, PassFort Limited, and Trussle, showcasing their effectiveness in nurturing early-stage startups. EF's investment philosophy prioritizes talent over pre-existing ideas, enabling them to partner with ambitious individuals early in their entrepreneurial journey. The firm has received backing from prominent figures and institutions, including Reid Hoffman, co-founder of LinkedIn, and John and Patrick Collison, co-founders of Stripe. This strong support system, coupled with EF's robust program, helps founders develop their ideas, find co-founders, and secure further investment from top-tier venture capital firms.

Entrepreneurs Roundtable Accelerator (ERA), founded in 2011, is New York City's leading technology accelerator and early-stage venture capital fund. ERA focuses on investing in startups at the forefront of various industries, including health care, financial services, future of work, commerce, and climate. ERA typically invests $150,000 in each company for a 6% stake through a post-money SAFE. The accelerator provides extensive support to its portfolio companies, including free office space, cloud hosting credits, and access to a network of over 1,000 expert mentors. This mentorship network is crucial in helping startups navigate the challenges of early-stage growth. Notable investments by ERA include Glia, TripleLift, Katapult, Thirty Madison, Nayya, Order, Bespoke Post, User Interviews, Fund That Flip, CardFlight, and Scentbird. ERA alumni companies have collectively raised over $2 billion in investor capital and exceed $10 billion in market capitalization. ERA is known for its robust support system, which includes talent acquisition, business development, community and networking, marketing, and PR. The accelerator's commitment to fostering innovation and entrepreneurship has positioned it as a pivotal player in New York's startup ecosystem​.

EPIC Ventures, based in Salt Lake City, Utah, is a venture capital firm that specializes in early-stage investments in technology sectors such as SaaS, healthcare, security, and fintech. Founded in 1994, EPIC Ventures has a long history of backing companies that are innovating in emerging markets. Some of their notable portfolio companies include Recursion Pharmaceuticals, Medsphere, and Health Catalyst, showcasing their strong focus on health and life sciences. The firm is also active in sectors like future of work and AI, with investments in xAI and Unlearn.AI. EPIC Ventures is known for its hands-on approach, providing not just capital but also strategic guidance and access to an extensive network of advisors. They work closely with the University of Utah through a joint venture called University of Utah Ventures, which focuses on supporting startups and commercialization efforts from academic research.

Epidarex Capital is a dynamic venture capital firm focusing on early-stage life science investments in under-ventured research hubs across the US and UK. The fund targets transformative opportunities in biotechnology, pharmaceuticals, medical devices, and health tech. Notable investments include Dunad Therapeutics, EM Imaging, and Leucid Bio. Established in 2010, Epidarex partners with leading universities and research institutions, providing crucial capital to spin out innovative technologies with the potential for significant patient impact and high financial returns. Their investment strategy prioritizes disruptive platform technologies addressing unmet medical needs, robust intellectual property portfolios, and early evidence of market validation. Epidarex is known for backing driven and tenacious founders, often providing seed or Series A funding. They maintain a rigorous evaluation process to ensure each investment has a sustainable competitive advantage and clear regulatory strategies. Epidarex's team, led by General Partner Elizabeth Roper, boasts extensive experience in the life sciences and venture capital sectors. Roper, with a background at The Wellcome Trust and Atlas Ventures, plays a pivotal role in shaping early-stage opportunities into successful companies. For startups looking to partner with Epidarex, it's crucial to demonstrate strong scientific foundations, clear commercialization pathways, and the potential for outstanding financial returns and patient benefits​.

Episode 1 Ventures, based in London, specializes in early-stage investments in technology companies across the UK. Founded in 2013, the firm focuses primarily on B2B software sectors, including AI, health tech, and software infrastructure. Their portfolio boasts notable investments such as Carwow, Triptease, and AimBrain. Episode 1 Ventures has recently launched a £76 million investment fund to support the next generation of tech startups. This fund is their largest yet and aims to provide substantial support to early-stage B2B firms, reflecting their commitment to fostering innovative UK-based companies​. The firm’s investment strategy typically involves making initial investments ranging from £250,000 to £3 million, guiding startups towards successful Series A rounds. They emphasize a hands-on approach, providing operational expertise and strategic guidance to help startups scale​. Key team members include Simon Murdoch, Adrian Lloyd, and Damien Lane, who bring extensive experience in entrepreneurship and investment. Their combined expertise ensures that Episode 1 Ventures can offer not just financial support, but also valuable mentorship and industry insights to their portfolio companies.

EQT Ventures is a powerhouse in the venture capital world, renowned for its robust investment portfolio and strategic prowess. The fund, managing €1.1 billion, focuses on early-stage tech startups, primarily in Europe and North America. Notable investments include Wolt, Peakon, and Airkit, showcasing its knack for backing high-potential companies. EQT Ventures targets industries like fintech, health tech, AI, mobile gaming, and sustainability. The fund is particularly interested in business models with scalable tech solutions that address real-world problems. Geographically, EQT Ventures has a strong presence in Europe and the US, with offices in major hubs like Stockholm, London, Berlin, Paris, and San Francisco. This broad reach helps them tap into diverse markets and innovation ecosystems. Their investment strategy is both aggressive and supportive, offering initial investments ranging from €1 to €50 million. EQT Ventures is known for its active involvement in scaling startups, leveraging a team of over 40 founders and operators. The advisory team, split equally between men and women, uses proprietary AI tools like Motherbrain to identify and nurture high-growth opportunities. Founders can expect a hands-on approach, with EQT Ventures providing not just capital, but also strategic guidance and operational support. The team, led by key figures like Lars Jörnow and Ashley Lundström, brings a wealth of experience and a track record of success in building global companies.

Equilibrium Capital is a sustainability-focused asset management firm, founded in 2008 with the mission to drive sustainable prosperity through capital markets. The firm is dedicated to investing in sustainable real assets, with a focus on two key sectors: sustainable food and agriculture, and carbon transition infrastructure. Equilibrium is committed to building investment portfolios that not only generate financial returns but also create positive environmental and societal impacts. The firm’s investment strategies are built on proprietary research, aiming to capture value from sustainability trends such as climate adaptation, net-zero goals, and changing consumer patterns. Equilibrium’s portfolio includes diverse investments that target resilience, resource efficiency, and sustainable business models in sectors that are reshaping the future. With a global presence, including offices in San Francisco, Portland, Singapore, and London, Equilibrium serves institutional investors by providing innovative and scalable sustainability-driven financial products. The firm is led by CEO and founder Dave Chen, who has a strong background in venture capital and sustainability finance.

Equinor Ventures is the corporate venture capital arm of Equinor, a global energy company based in Norway. The firm focuses on investing in innovative early-phase and growth companies that are shaping the future of energy, with a particular emphasis on technologies that support the transition to a low-carbon future. Over the next five years, Equinor Ventures plans to deploy $750 million, with 70% of this capital directed toward renewable energy, low-carbon solutions, and new energy opportunities. Their portfolio spans a wide range of sectors, including renewable energy, alternative energy technologies, and clean tech. Recent investments include companies like Commonwealth Fusion Systems, which aims to commercialize fusion energy, and Space Intelligence, which uses satellite data to track and protect tropical forests. Equinor Ventures typically takes a minority equity share in these ventures, with individual investments ranging from under $1 million to over $70 million, depending on the project's phase and size. Beyond capital, Equinor Ventures offers strategic support, including technical guidance and market access, helping startups scale their technologies and explore new business models. They are also involved in accelerator programs like the Equinor & Techstars Energy Accelerator, aimed at fostering innovation in the energy sector. Equinor Ventures is geographically focused on Europe and North America but remains open to global opportunities that align with their mission of driving the energy transition forward.

Esco Ventures, the investment arm of Singapore-based Esco Group, focuses on early-stage life sciences and medtech startups. The firm specializes in areas like biotech, diagnostics, and women’s health, aiming to nurture groundbreaking technologies that improve global health. What sets Esco Ventures apart is its hands-on approach, offering startups more than capital by providing mentoring, productization, manufacturing support, and global distribution networks through its parent company, Esco Group. Esco Ventures plays a crucial role in shaping the next wave of medical innovations, drawing on Esco Group’s decades of experience in life sciences. Their investment philosophy is built around long-term growth, with an emphasis on addressing unmet medical needs through disruptive technologies. The firm has a global reach but maintains a particular focus on Singapore, aligning with the nation’s vision to become a biomedical innovation hub in Asia. Under the leadership of Managing Partner XiangQian Lin, Esco Ventures works closely with scientists, engineers, and entrepreneurs, guiding them from ideation to commercialization. The firm has already seen success with investments like a Danish/Lithuanian medical device company, which achieved 5x growth within three years. Esco Ventures also actively supports the local Singaporean ecosystem by mentoring early-stage researchers and startups even before formal incorporation, fostering a collaborative and innovative environment aimed at creating the next big breakthroughs in life sciences and medtech.

Eurazeo is a prominent global investment group with approximately €35 billion in assets under management, including €24 billion managed on behalf of institutional and private clients. The firm specializes in private equity, private debt, and real assets, with investments spanning consumer, healthcare, tech-enabled services, and financial services sectors. Notable investments include high-profile companies like Moncler, Farfetch, Vestiaire Collective, Asmodee, and Orolia, as well as tech companies like Deezer and Onfido. Eurazeo’s strategy focuses on identifying and accelerating the growth potential of their portfolio companies through capital investment and strategic support. Eurazeo operates across various investment strategies, including buyouts, growth capital, venture capital, and real assets. With offices in Europe, North America, and Asia, Eurazeo has a diverse geographic reach and is committed to long-term value creation with a responsible investment approach.

Eureka! Venture SGR, established in 2019, is Italy's first independent venture capital firm focusing exclusively on deep tech investments. Based in Milan and Rome, Eureka! specializes in transformative technologies, including AI, energy, health and well-being, mobility, and environmental innovations. The firm manages Eureka! Fund I, a technology transfer fund designed to bridge the gap between scientific discovery and commercial success. With a focus on startups born from cutting-edge research, Eureka! aims to foster the development of deep tech solutions that have the potential to revolutionize industries. Their portfolio includes startups like BeDimensional (nanotechnology) and ReHouseIt (sustainable construction), reflecting their commitment to impactful innovation. Eureka! also adheres to strict ESG (Environmental, Social, Governance) principles, aligning their investments with the UN's 2030 Sustainable Development Goals. The firm’s leadership, including CEO Stefano Peroncini and co-founder Anna Amati, brings over 25 years of experience in venture investing and technology transfer. This expertise enables them to guide startups from initial innovation to market, leveraging strategic partnerships with universities and research institutions across Europe. In addition to deep tech, Eureka! operates the BlackSheep Fund, which invests in late-stage European tech companies transforming the marketing industry through AI and big data.

The European Circular Bioeconomy Fund (ECBF) is a specialized venture capital fund dedicated to driving the transition from a fossil-based to a bio-based economy in Europe. Established in 2020 and headquartered in Luxembourg, ECBF was initiated with support from the European Union to fill a critical funding gap identified in the growth phase of bioeconomy companies. The fund, managed by Hauck & Aufhäuser Funds Services S.A. and advised by ECBF Management GmbH, has raised €300 million, surpassing its initial target of €250 million. ECBF focuses on investing in growth-stage companies that contribute to the circular bioeconomy, aiming to support innovative entrepreneurs whose technologies can revolutionize industries and promote sustainability. The fund's portfolio includes companies across various sectors such as bio-based materials, agritech, and bioplastics. ECBF's investments align with the European Green Deal goals, particularly the aim to make Europe climate neutral by 2050. The fund's approach combines financial support with strategic guidance, leveraging a diverse and experienced team to help portfolio companies achieve both environmental impact and favorable financial returns. Investors in ECBF include a mix of public and private entities from across Europe, reflecting broad support for advancing the bioeconomy sector.

Everywhere Ventures, previously known as "The Fund," is a global pre-seed venture capital firm founded in 2018 by Jenny Fielding, Scott Hartley, and several other partners. The firm takes a unique approach by building a community of over 500 founders and operators who actively support one another. This "many-to-many" model is distinct from traditional VC structures, emphasizing collaboration within its network. Everywhere Ventures typically invests between $50,000 and $250,000 in pre-seed startups, generally participating in rounds of $500,000 to $2 million. The firm has backed more than 250 companies across a range of industries, with a core focus on the future of money, health, and work. Their portfolio includes businesses that are redefining sectors through technology and innovation, with the firm often leading or syndicating deals. Everywhere Ventures is committed to supporting early-stage founders globally, particularly those with big ideas and bold visions, even if they lack traction. With its strong emphasis on founder support and global reach, the firm has quickly become a go-to for first-time entrepreneurs​.

Evolution VC Partners is a New York-based venture capital firm focused on "culture-tech" investments—companies that are reshaping how people work, live, and interact with technology. Established by Gregg Smith, the firm primarily invests in sectors such as advanced materials, 3D printing, fintech, media, entertainment, digital health, life sciences, and plant-based innovations. Their goal is to support disruptive companies that are defining today's culture and paving the way for future societal shifts. The firm is stage-agnostic, meaning it invests in companies at various phases, from early-stage to growth-stage ventures. Evolution VC Partners works closely with founders, providing not just capital but also strategic advice to accelerate growth. Their portfolio includes notable companies like Instacart, Rodo, DailyPay, and Axiom Space. What sets Evolution apart is that it operates solely with the founder's personal capital, allowing for more flexibility and focus on long-term impact rather than external fund performance​.